Affiliations
AffiliationsItem in Clipboard
The global decrease in cancer mortality: trends and disparitiesD Hashim et al. Ann Oncol. 2016 May.
Free article doi: 10.1093/annonc/mdw027. Epub 2016 Jan 22. AffiliationsItem in Clipboard
AbstractBackground: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear.
Design: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate.
Results: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'.
Conclusions: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Keywords: cancer; data collection/standards; global health; mortality; registries/standards; vital statistics.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articlesHoel DG, Davis DL, Miller AB, Sondik EJ, Swerdlow AJ. Hoel DG, et al. J Natl Cancer Inst. 1992 Mar 4;84(5):313-20. doi: 10.1093/jnci/84.5.313. J Natl Cancer Inst. 1992. PMID: 1738181
Carioli G, Malvezzi M, Bertuccio P, Hashim D, Waxman S, Negri E, Boffetta P, La Vecchia C. Carioli G, et al. Ann Oncol. 2019 Aug 1;30(8):1344-1355. doi: 10.1093/annonc/mdz178. Ann Oncol. 2019. PMID: 31147682
Sedeta E, Sung H, Laversanne M, Bray F, Jemal A. Sedeta E, et al. Cancer Epidemiol Biomarkers Prev. 2023 Jul 5;32(7):894-905. doi: 10.1158/1055-9965.EPI-22-1133. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 37195435
Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Torre LA, et al. Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457. doi: 10.1158/1055-9965.EPI-16-0858. Epub 2017 Feb 21. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28223433 Review.
Ruthström T, Hägg L, Johansson L, Lind MM, Johansson M. Ruthström T, et al. Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241293337. doi: 10.1177/10760296241293337. Clin Appl Thromb Hemost. 2024. PMID: 39449367 Free PMC article.
Wang H, Wang R, Huang D, Li S, Gao B, Kang Z, Tang B, Xie J, Yan F, Liang R, Li H, Yan J. Wang H, et al. Front Pharmacol. 2021 Feb 24;12:592071. doi: 10.3389/fphar.2021.592071. eCollection 2021. Front Pharmacol. 2021. PMID: 33716735 Free PMC article.
Chen J, Zhang M, Ma Z, Yuan D, Zhu J, Tuo B, Li T, Liu X. Chen J, et al. Cell Oncol (Dordr). 2021 Aug;44(4):739-749. doi: 10.1007/s13402-021-00604-1. Epub 2021 Apr 15. Cell Oncol (Dordr). 2021. PMID: 33856653 Free PMC article. Review.
Han KT, Kim S. Han KT, et al. J Clin Med. 2021 May 27;10(11):2361. doi: 10.3390/jcm10112361. J Clin Med. 2021. PMID: 34072162 Free PMC article.
Huang YH, Lee MS, Lou YS, Lai HC, Yu JC, Lu CH, Wong CS, Wu ZF. Huang YH, et al. PLoS One. 2019 Nov 7;14(11):e0224728. doi: 10.1371/journal.pone.0224728. eCollection 2019. PLoS One. 2019. PMID: 31697743 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3